Last update:

Gastroenterology news

High-fat diet-linked dysbiosis may send gut bacteria to the brain via vagus nerve

Gut dysbiosis caused by a high-fat diet can allow bacteria to move from the gut to the brain in mice, according to a new study by David Weiss and Arash Grakoui from Emory University, U.S., and colleagues published in the ...

An experimental model reproduces creeping fat associated with Crohn's disease and facilitates its study

A team of researchers from the Germans Trias i Pujol Research Institute (IGTP) and the Institut de Recerca Biomèdica Catalunya Sud (IRB CatSud, formerly IISPV) has published a study in the journal Inflammatory Bowel Diseases ...

Specific gut bacteria species linked to muscle strength

A species of gut bacteria called Roseburia inulinivorans is specifically associated with human muscle strength and improved muscular performance in mice, finds research published online in the journal Gut.

GI cancers to double by 2050, experts warn

Gastrointestinal cancer cases are expected to double worldwide by 2050, according to a multi-institutional study co-led by Cedars-Sinai. The projections, based on 2022 data and published in the journal Cancer, conclude that ...

Bariatric surgery in a pill bottle

More than 37 million Americans have type 2 diabetes, a chronic disorder affecting the body's ability to regulate and use sugar. According to the CDC, it's the country's seventh leading cause of death. Type 2 diabetes can ...

Common toxin linked to liver disease

Liver disease is usually caused by one of three factors: alcohol consumption, fat buildup in the liver linked to obesity, diabetes and high cholesterol, or hepatitis B and C.

Two-drug combination could improve colorectal cancer therapy

Colorectal cancer is one of the most common tumors among people over the age of 50. Although it is known to develop from small lesions or polyps, its exact causes are unknown—only a few risk factors are known—and it is ...

Zenocutuzumab shows clinical benefit in rare bile duct cancer

Zenocutuzumab (Bizengri), a bispecific antibody that targets human epidermal growth factor receptor 2 (HER2) and HER3, led to responses in more than a third of patients with neuregulin 1 (NRG1)-positive cholangiocarcinoma, ...

Preventing malnutrition in people with blood cancer

Malnutrition is a common but difficult-to-manage complication for people with cancer, especially those treated with intensive chemotherapy. Now, new research from the University of Adelaide has delivered new insights into ...